273 related articles for article (PubMed ID: 33262574)
1. Functional Measurement of CYP2C9 and CYP3A4 Allelic Polymorphism on Sildenafil Metabolism.
Tang PF; Zheng X; Hu XX; Yang CC; Chen Z; Qian JC; Cai JP; Hu GX
Drug Des Devel Ther; 2020; 14():5129-5141. PubMed ID: 33262574
[TBL] [Abstract][Full Text] [Related]
2. Effects of cytochrome P450 2C9 polymorphism on bosentan metabolism.
Chen M; Zhang Y; Pan P; Wang L; Zhan Y; Jin H; Xia M; Wang X; Dai D; Cai J; Hu G
Drug Metab Dispos; 2014 Nov; 42(11):1820-5. PubMed ID: 25142737
[TBL] [Abstract][Full Text] [Related]
3. Functional characterization of 21 CYP3A4 variants on amiodarone metabolism in vitro.
Yang CC; Zheng X; Liu TH; Wang CC; Tang PF; Chen Z; Zhang BW; Fang P; Hu GX; Cai JP
Xenobiotica; 2019 Jan; 49(1):120-126. PubMed ID: 29394111
[TBL] [Abstract][Full Text] [Related]
4. In vitro metabolism of phenytoin in 36 CYP2C9 variants found in the Chinese population.
Chen LG; Wang Z; Zhu Y; Xiong JH; Sun LR; Dai DP; Cai JP; Hu GX
Chem Biol Interact; 2016 Jun; 253():93-9. PubMed ID: 27163851
[TBL] [Abstract][Full Text] [Related]
5. Effect of CYP2C9 genetic polymorphism on the metabolism of flurbiprofen in vitro.
Wang L; Bao SH; Pan PP; Xia MM; Chen MC; Liang BQ; Dai DP; Cai JP; Hu GX
Drug Dev Ind Pharm; 2015; 41(8):1363-7. PubMed ID: 25144335
[TBL] [Abstract][Full Text] [Related]
6. The role of CYP2C9 genetic polymorphisms in the oxidative metabolism of diclofenac in vitro.
Xia MM; Wang L; PAan PP; Wang HY; Chen MC; Chen Y; Dai DP; Cai JP; Hu GX
Pharmazie; 2014 Dec; 69(12):898-903. PubMed ID: 25951663
[TBL] [Abstract][Full Text] [Related]
7. Functional assessment of
Fang P; Tang PF; Xu RA; Zheng X; Wen J; Bao SS; Cai JP; Hu GX
Drug Des Devel Ther; 2017; 11():3503-3510. PubMed ID: 29263648
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Recombinant CYP3A4 Variants on the Metabolism of Oxycodone In Vitro.
Cai Y; Lin Q; Jin Z; Xia F; Ye Y; Xia Y; Papadimos TJ; Wang Q; Hu G; Cai J; Chen L
Chem Res Toxicol; 2021 Jan; 34(1):103-109. PubMed ID: 33393779
[TBL] [Abstract][Full Text] [Related]
9. Identification of the cytochrome P450 enzymes involved in the N-demethylation of sildenafil.
Hyland R; Roe EG; Jones BC; Smith DA
Br J Clin Pharmacol; 2001 Mar; 51(3):239-48. PubMed ID: 11298070
[TBL] [Abstract][Full Text] [Related]
10. Functional evaluation of vandetanib metabolism by CYP3A4 variants and potential drug interactions in vitro.
Han M; Zhang X; Ye Z; Wang J; Qian J; Hu G; Cai J
Chem Biol Interact; 2021 Dec; 350():109700. PubMed ID: 34648813
[TBL] [Abstract][Full Text] [Related]
11. Enzymatic activity on valsartan of 38 CYP2C9 variants from the Chinese population.
Yuan LJ; Qian JC; Li XY; Cui J; Cai JP; Hu GX
Chem Biol Interact; 2022 Feb; 353():109799. PubMed ID: 34998819
[TBL] [Abstract][Full Text] [Related]
12. In vitro assessment of 36 CYP2C9 allelic isoforms found in the Chinese population on the metabolism of glimepiride.
Dai DP; Wang SH; Geng PW; Hu GX; Cai JP
Basic Clin Pharmacol Toxicol; 2014 Apr; 114(4):305-10. PubMed ID: 24118918
[TBL] [Abstract][Full Text] [Related]
13. The influence of temperature on the metabolic activity of CYP2C9, CYP2C19, and CYP3A4 genetic variants
Kojima M; Machida K; Cho S; Watanabe D; Seki H; Shimoji M; Imaoka A; Yamazaki H; Guengerich FP; Nakamura K; Yamamoto K; Akiyoshi T; Ohtani H
Xenobiotica; 2023 May; 53(5):357-365. PubMed ID: 37584614
[TBL] [Abstract][Full Text] [Related]
14. Functional characterization of 27 CYP3A4 protein variants to metabolize regorafenib in vitro.
Li YH; Lin QM; Pang NH; Zhang XD; Huang HL; Cai JP; Hu GX
Basic Clin Pharmacol Toxicol; 2019 Oct; 125(4):337-344. PubMed ID: 31058459
[TBL] [Abstract][Full Text] [Related]
15. Effect of CYP2C9 Genetic Polymorphism in a Chinese Population on the Metabolism of Mestranol in vitro.
Hu JH; Wang L; Li WS; Dai DP; Cai JP; Hu GX
Pharmacology; 2015; 95(5-6):218-23. PubMed ID: 25924705
[TBL] [Abstract][Full Text] [Related]
16. In vitro assessment of 39 CYP2C9 variants found in the Chinese population on the metabolism of the model substrate fluoxetine and a summary of their effects on other substrates.
Ji Y; Chen S; Zhao L; Pan P; Wang L; Cai J; Dai D; Hu G; Cai JP; Huang H
J Clin Pharm Ther; 2015 Jun; 40(3):320-7. PubMed ID: 25884291
[TBL] [Abstract][Full Text] [Related]
17. Impact of CYP2C9 polymorphism found in the Chinese population on the metabolism of propofol in vitro.
Lian QQ; Pan PP; Li JW; Lin H; Hu GX; Zuo MZ; Cai JP
Biol Pharm Bull; 2015; 38(4):531-5. PubMed ID: 25832633
[TBL] [Abstract][Full Text] [Related]
18. Functional Analysis of Wild-Type and 27 CYP3A4 Variants on Dronedarone Metabolism
Wang CC; Lan T
Curr Drug Metab; 2022; 23(7):562-570. PubMed ID: 35702776
[TBL] [Abstract][Full Text] [Related]
19. Function of 38 variants CYP2C9 polymorphism on ketamine metabolism in vitro.
Zheng X; Fang P; Bao SS; Lin D; Cai JP; Hu GX
J Pharmacol Sci; 2017 Sep; 135(1):8-13. PubMed ID: 28927781
[TBL] [Abstract][Full Text] [Related]
20. Effect of 36 CYP2C9 variants found in the Chinese population on losartan metabolism in vitro.
Wang YH; Pan PP; Dai DP; Wang SH; Geng PW; Cai JP; Hu GX
Xenobiotica; 2014 Mar; 44(3):270-5. PubMed ID: 23844998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
